Achmea Investment Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-61,849
| Closed | -$47.2M | – | 225 |
|
|
2025
Q3 | $47.2M | Sell |
61,849
-2,684
| -4% | -$2M | 0.59% | 35 |
|
|
2025
Q2 | $50.3M | Buy |
64,533
+703
| +1% | +$546K | 0.65% | 31 |
|
|
2025
Q1 | $52.7M | Buy |
63,830
+4,980
| +8% | +$4.14M | 0.77% | 24 |
|
|
2024
Q4 | $45.4M | Sell |
58,850
-996
| -2% | -$825K | 0.75% | 26 |
|
|
2024
Q3 | $53M | Sell |
59,846
-889
| -1% | -$799K | 0.87% | 18 |
|
|
2024
Q2 | $55M | Buy |
60,735
+364
| +0.6% | +$291K | 0.98% | 17 |
|
|
2024
Q1 | $47M | Sell |
60,371
-11,627
| -16% | -$8.27M | 0.89% | 21 |
|
|
2023
Q4 | $42M | Sell |
71,998
-5,551
| -7% | -$3.24M | 0.87% | 20 |
|
|
2023
Q3 | $41.7M | Buy |
77,549
+830
| +1% | +$428K | 0.91% | 19 |
|
|
2023
Q2 | $36M | Buy |
76,719
+15,505
| +25% | +$6.5M | 0.76% | 22 |
|
|
2023
Q1 | $21M | Buy |
61,214
+6,685
| +12% | +$2.25M | 0.61% | 32 |
|
|
2022
Q4 | $18.7M | Sell |
54,529
-2,091
| -4% | -$741K | 0.63% | 28 |
|
|
2022
Q3 | $18.3M | Sell |
56,620
-12,334
| -18% | -$3.91M | 0.65% | 28 |
|
|
2022
Q2 | $22.4M | Buy |
68,954
+175
| +0.3% | +$52.5K | 0.72% | 26 |
|
|
2022
Q1 | $19.7M | Sell |
68,779
-8,996
| -12% | -$2.32M | 0.51% | 34 |
|
|
2021
Q4 | $21.5M | Sell |
77,775
-4,938
| -6% | -$1.25M | 1.02% | 16 |
|
|
2021
Q3 | $19.1M | Sell |
82,713
-5,997
| -7% | -$1.48M | 0.58% | 29 |
|
|
2021
Q2 | $20.4M | Buy |
88,710
+2,642
| +3% | +$531K | 0.69% | 22 |
|
|
2021
Q1 | $16.1M | Sell |
86,068
-2,206
| -2% | -$432K | 0.56% | 32 |
|
|
2020
Q4 | $14.9M | Buy |
88,274
+16,070
| +22% | +$2.4M | 0.54% | 35 |
|
|
2020
Q3 | $10.7M | Buy |
+72,204
| New | +$11.2M | 0.45% | 48 |
|
|
2020
Q1 | – | Sell |
-89,946
| Closed | -$11.8M | – | 421 |
|
|
2019
Q4 | $11.8M | Sell |
89,946
-5,831
| -6% | -$676K | 0.46% | 47 |
|
|
2019
Q3 | $10.7M | Sell |
95,777
-78,465
| -45% | -$8.74M | 0.42% | 47 |
|
|
2019
Q2 | $19.3M | Buy |
174,242
+8,719
| +5% | +$1.03M | 0.74% | 28 |
|
|
2019
Q1 | $21.5M | Sell |
165,523
-17,994
| -10% | -$2.19M | 0.89% | 22 |
|
|
2018
Q4 | $21.2M | Buy |
183,517
+75,939
| +71% | +$8.48M | 0.98% | 22 |
|
|
2018
Q3 | $11.5M | Buy |
107,578
+11,050
| +11% | +$1.1M | 0.44% | 52 |
|
|
2018
Q2 | $8.23M | Hold |
96,528
| – | – | 0.29% | 86 |
|
|
2018
Q1 | $7.46M | Sell |
96,528
-23,941
| -20% | -$1.93M | 0.25% | 105 |
|
|
2017
Q4 | $10.2M | Buy |
120,469
+67,178
| +126% | +$5.72M | 0.34% | 71 |
|
|
2017
Q3 | $4.56M | Sell |
53,291
-1,593
| -3% | -$131K | 0.26% | 101 |
|
|
2017
Q2 | $4.51M | Buy |
54,884
+22,714
| +71% | +$1.85M | 0.27% | 92 |
|
|
2017
Q1 | $2.71M | Buy |
+32,170
| New | +$2.58M | 0.13% | 206 |
|
Other funds holding LLY
Achmea Investment Management's LLY Position: Q4 2025 in Review
Achmea Investment Management sold out of Eli Lilly (LLY) in Q4 2025, closing a stake of 61,849 shares — an estimated $47.2M sold.
Achmea Investment Management first reported a position in LLY in Q1 2017 and held it in 33 quarters. The position peaked at $55M in Q2 2024. 4,441 funds tracked by Wall St. Rank hold LLY as of Q4 2025.
- Achmea Investment Management reported no remaining Eli Lilly position as of Q4 2025 after selling out during the quarter.
- Achmea Investment Management sold 61,849 Eli Lilly shares in Q4 2025, an estimated $47.2M.
- Achmea Investment Management first reported a position in Eli Lilly in Q1 2017 and held it in 33 quarters.
- Achmea Investment Management's Eli Lilly position peaked at $55M in Q2 2024.
- 4,441 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2025.
Based on Achmea Investment Management's 13F filing for Q4 2025, filed 18 Feb 2026.